Clinical trial Recruiting at 1 site Observational Ages 1 Day to 18

Monitoring whooping cough in children in outpatient settings

Official title: National Surveillance of Pediatric Pertussis in Ambulatory Settings

Run by Association Clinique Thérapeutique Infantile du val de Marne · NCT04807712 · Data updated 2026-11-12

This study looks at how well whooping cough vaccines protect children under 18 in France and tracks their health if they get sick with the disease.

Quick facts

Study typeObservational
Ages1 Day to 18 Years
SexAll
Enrollment898 (estimated)
SponsorAssociation Clinique Thérapeutique Infantile du val de Marne
Academic / other
Locations1 site (Créteil)
StatusRecruiting
StartedMay 30, 2001
Main results expectedJanuary 1, 2030
Study endsJanuary 1, 2030
Registry record updatedFebruary 8, 2024
Trial IDNCT04807712 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children aged 0-18 years with a suspected diagnosis of pertussis who require a biological examination.

Probably not a fit

Patients who are asymptomatic but have a confirmed family case of pertussis may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the surveillance of whooping cough (pertussis) in children under 18 years old in France, particularly those vaccinated with acellular vaccines. It aims to assess the duration of protection provided by these vaccines and to analyze clinical characteristics of vaccinated children. The study involves collecting data during initial visits when pertussis is suspected and during follow-up visits to monitor outcomes and laboratory results. It also includes training for laboratories on diagnostic procedures and monitoring infections caused by related bacteria.

Why it matters

Potential benefit: If successful, this study could enhance understanding of pertussis vaccine effectiveness and inform future vaccination strategies for children.

How similar studies have gone: Previous studies have shown success in monitoring vaccine effectiveness and disease characteristics, making this approach both relevant and valuable.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All children under 18 years old with a pertussis diagnosis is suspected and a biological exam is requested

Exclusion Criteria:

* children without symptoms with a household confirmed case
* cases for which the pertussis diagnosis was not suspected by the pediatrician

Where it's running

  • Activ
    Créteil, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.